In this dynamic global landscape, investors have always been required to make savvy, smart choices. This requires navigating through the intricate web of bilateral treaty protection, exploring the vital role these agreements...more
12/20/2023
/ Acquisitions ,
Bilateral Investment Treaties ,
Buyers ,
Carve Out Provisions ,
Cross-Border Transactions ,
Energy Sector ,
EU ,
Financial Regulatory Reform ,
Foreign Investment ,
Foreign Subsidiaries ,
Foreign Subsidies ,
Healthcare ,
Hedging ,
International Trade ,
Investment ,
Investors ,
Jurisdiction ,
Life Sciences ,
Mergers ,
Regulatory Agenda ,
Sellers ,
Sports ,
Technology Sector ,
UK
McDermott is committed to provide insightful legal developments around the world to our Japanese clients. In light of that effort, Japan Webinar Series will be held between Thursday, May 20 – Thursday, June 3, 2021.
This...more
5/12/2021
/ Anti-Money Laundering ,
Antitrust Division ,
Antitrust Provisions ,
Antitrust Violations ,
Best Practices ,
Biden Administration ,
Buy America ,
Civil Liability ,
Collusion ,
Comment Period ,
Competition ,
Competition Authorities ,
Compliance ,
Cooperation ,
Criminal Liability ,
Cross-Border Transactions ,
Department of Justice (DOJ) ,
Enforcement Priorities ,
EU ,
European Commission ,
Federal Trade Commission (FTC) ,
Internal Investigations ,
Japan ,
Mergers ,
Procurement Collusion Strike Force ,
Public Comment ,
Public Procurement Policies ,
Risk Mitigation ,
Section 201 ,
Section 232 ,
Section 301 ,
Section 337 ,
US Trade Policies ,
Webinars ,
Whistleblower Protection Policies ,
Whistleblowers
Expect More Criminal Enforcement & What You Can Do To Minimize Your Risk -
Antitrust cartel and related collusive scheme enforcement is poised to increase. Several factors support this: (1) the Antitrust Division (the...more
5/10/2021
/ Compliance ,
Cross-Border Transactions ,
Data Protection ,
Department of Justice (DOJ) ,
Enforcement Actions ,
EU ,
European Commission ,
European Data Protection Board (EDPB) ,
European Economic Area (EEA) ,
General Data Protection Regulation (GDPR) ,
Pharmaceutical Industry ,
Proposed Legislation ,
Risk Management ,
UK Brexit